USPTO Deadlines
Next Deadline
336 days remaining
Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20201117)
Due Date
November 17, 2026
Grace Period Ends
May 17, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
13 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jan 22, 2021 | GPNX | P | NOTIFICATION PROCESSED BY IB | Loading... |
| Jan 5, 2021 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB | Loading... |
| Jan 5, 2021 | FIMP | P | FINAL DISPOSITION PROCESSED | Loading... |
| Dec 17, 2020 | GPAR | P | GRANT OF PROTECTION CREATED, TO BE SENT TO IB | Loading... |
| Nov 17, 2020 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Sep 1, 2020 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Aug 12, 2020 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| Jul 28, 2020 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Jul 27, 2020 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jul 22, 2020 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jul 22, 2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jul 21, 2020 | LIMI | I | LIMITATION FROM ORIGINAL APPLICATION ENTERED | Loading... |
| Jul 16, 2020 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for human use for the treatment of neurological diseases and disorders, immunological diseases and disorders, inflammatory diseases and disorders, oncological diseases and disorders and viral infections, as well as for the treatment of CAR T-cell induced cytokine release syndrome
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005